Press Releases

DENVER, Feb. 7, 2020 /PRNewswire/ -- CBD of Denver, Inc. (OTC:CBDD), a full-line CBD / Hemp oil company ("CBDD") that sells Black Pearl CBD / Hemp Products and the owner of CBD Social Network, is pleased to announce that its has signed a definitive agreement with I'M Canabiz, AG with regards to a reverse merger.

SALT LAKE CITY, Feb. 7, 2020 /PRNewswire/ -- According to the Centers for Disease Control and Prevention, suicide is the tenth leading cause of death in the United States and the seventh leading cause of death in Utah.  On Thursday, February 13, advocates fro

LOS ANGELES, Feb. 7, 2020 /PRNewswire/ -- With the increasing incidence of Alzheimer's disease and dementia, affected families are all too often "stretched to the breaking point," according to Kara Bonela, Vice President, Marketing, Alzheimer's Los Angeles.  To support those affected and their families and caregivers, the short dramatic live-action film "Mot

DUBLIN, Feb. 7, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of Quality, Affordable Self-Care Products™, today announced the future retirement of Jeff Needham, Executive Vice President and President, Consumer Self-Care Americas (CSCA). Rich Sor

MELBOURNE, Australia and SAN FRANCISCO, Feb. 7, 2020 /PRNewswire/ -- Alterity Therapeutics Limited (ASX:ATH, NASDAQ:ATHE) has received notification from the Listing Qualifications Department of NASDAQ advising the Company that it is currently non-compliant with NASDAQ's requirement that listed securities maintain a minimum bid

HUNTINGTON BEACH, Calif., Feb. 7, 2020 /PRNewswire/ -- Many people see gambling solely as a way to raise the stakes on major sporting events or kill some time on vacation.  You may like to get an office pool together to bet on the Super Bowl or to see who builds the best Final Four bracket.  But in the internet age, gambling is no longer limited to friendly wa

NORTH CHICAGO, Ill., Feb. 7, 2020 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the fourth quarter and full year ended December 31, 2019."Our strong performance this quarter completes another excellent year for AbbVie," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "The launches of Skyrizi and Rinvoq are goin

VANCOUVER, Feb. 7, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), will report financial results for the second quarter of fiscal yea

LEIDEN, Netherlands, Feb. 7, 2020 /PRNewswire/ -- Pharvaris B.V., a clinical-stage company focused on the discovery and development of novel oral B2-receptor antagonists for the tre

AUSTIN, Texas, Feb. 7, 2020 /PRNewswire/ -- Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced that the Company presented a subgroup analysis of the prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating its personalized tumor lysate, particle-loaded,